Gatorgunk
Posted - 1 day ago
$CAPR anyone on this board in $MIRM ?
xbibackto70s
Posted - 2 days ago
$MIRM ok fine f it I’ll add more
xbibackto70s
Posted - 2 days ago
$MIRM f this co!
LMXPERTEN
Posted - 3 days ago
$MIRM pinned at 1.2 BUSD.
Mgt if professional should start cut costs. No need for preclinical researchers overall (should have nothing in pipeline!), also black hole sales force (what are they doing?!) to be overseen.
IAs better be positive or we see sub20. IAs highly risky overall.
Co is today valued to same as ALBO. Makes sense and not a surprise for a skilled investor.
newsfile_corp
Posted - 3 days ago
https://nfne.ws/207796 $CNTB $IRWD $MIRM $THAR #NASDAQ #Investing
xbibackto70s
Posted - 3 days ago
$MIRM gild would be smart to buy this after Cbay purchase.
xbibackto70s
Posted - 3 days ago
$MIRM adding even more I see a BO soon
xbibackto70s
Posted - 3 days ago
$MIRM adding
xbibackto70s
Posted - 4 days ago
$MIRM adding bunch back
Stock_Titan
Posted - 4 days ago
$MIRM Mirum Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
https://www.stocktitan.net/news/MIRM/mirum-pharmaceuticals-to-announce-first-quarter-2024-financial-8odztysdnc95.html
LMXPERTEN
Posted - 04/29/24
$MIRM pre read out speculation has started. Black or red? Casino 🎰
valueforme
Posted - 04/28/24
$FOLD $MIRM $BCRX This is getting ridiculous
LMXPERTEN
Posted - 04/25/24
$MIRM completely dead forum. No one carese about the stock. Short term with two IAs. Pos IAs+ 1-10 dollars. Neg IAs Drop 3-8 dollars. 0-6 months. Midterm. +5 to -10. From todays levels. Likely drop no matter IA outcome. 6-18 months.
Longterm. +5-10 dollars from today’s levels. 18-32 months
Gamechanger? BO. Price dependant on IAs but assume 30 dollars lowest with neg IAs. Could fly to 50 if all goes Mirum’s way.
Catalysts? With neg IAs dead already July.
With pos IAs will have catalysts foremost from July-Dec 2025, ie dead money for a year the least.
LMXPERTEN
Posted - 04/25/24
$MIRM goooing deeeeep in the shiiiets. Can se see sub 23 already today?
Nosh
Posted - 04/23/24
$MIRM Too many high price targets here and it is languishing. Eventually it has to come to an end. Entering here...right underneath support and shakeout area...starter in case it can't recapture $25 with volume.
LMXPERTEN
Posted - 04/19/24
$MIRM where are all these noisy authors, bragging and behaving like SH-T vs. Other human beings? I know. They are hiding under a rock, counting the crumbles of their invested money. What we call them? AMATEURS. MIRM will soon stabilize. Until IA(s). If IA is sh-t, then we see baddy baddy bad sub 20. If IA is good, then we see up a bit but eventuelly badaaaam fall back again. krillionaire should have been respectful to an XPERT.
LMXPERTEN
Posted - 04/18/24
$MIRM krillionaire WRONG
LMXPERTEN 109% right. Amateur!
Quantumup
Posted - 04/16/24
Stifel🏁 $MIRM Buy/$48 ALGS/PFIC FDA approval establish⬇️side protection, altho small indications, these are noteworthy wins that validate the IBATI mech/steer MIRM's strat2conditions where the mech may engender benefit in the form of ameliorating/relieving pruritus, if not more:
DonCorleone77
Posted - 04/16/24
$MIRM Mirum Pharmaceuticals initiated with a Buy at Stifel Stifel analyst Dae Gon Ha initiated coverage of Mirum Pharmaceuticals with a Buy rating and $48 price target. Mirum has secured FDA approvals in rare cholestatic conditions Alagille syndrome, or ALGS, and progressive familial intrahepatic cholestasis, or PFIC, notes the analyst. Although small, these are "noteworthy wins" that validate the ileal bile acid transporter inhibitor, or IBATi, mechanism and steer the company's strategy to conditions where the mechanism of action may "engender benefit in the form of ameliorating/relieving pruritus, if not more," the analyst tells investors.
Krillionaire
Posted - 04/16/24
$MIRM bumpy ride :/ Still have my 30k shares. Not going anywhere. the longer this fear mongering continues, the more on sale this company becomes. I’m only Antsy about whether this negative price action will continue into the summer when I free up 800k to invest. I’d love if it doesn’t take off until then. It’s a ticking clock until people reassess revenues of 320mil/year+growth and see how nuts this price is, with current assets only. @valueforme and I go way back, and his dd is legendary. I would add to his comment about the lease agreement that a business has to commit to a facility that provides growth. That does not necessarily say it won’t be acquired soon, as a past company of mine personally signed a 5 year lease and got picked up 2 months into it. Sigh. Business has to scale regardless of negotiation, as waiting for our price charming big pharma could negatively effect ops, and ultimately, price tag. Go enjoy your families. Go outside. Most importantly, block the noise.
Quantumup
Posted - 04/16/24
Citi opened a 90-day upside catalyst watch on $MIRM (Buy/$37): ‘‘Interim analysis of volixibat's Ph2b VISTAS trial in primary sclerosing cholangitis (PSC) is expected in 1H24. We believe volixibat has potential to meet the company's prespecified (but undisclosed) benefit threshold, allowing the trial to proceed to a pivotal phase. We believe such an update will boost the Street's confidence in the PSC program as well as the volixibat's primary biliary cholangitis (PBC) readout (expected shortly after VISTAS), which should lead to stock upside.’’
Polip
Posted - 04/15/24
$MIRM there is a Swede annoying guy here constantly talking shit about others here on the board. He is too toxic I had to block him. He is simply waiting for a good entry price to invest his alleged 200k and he is manipulating the board with stupid messages. I don’t think you will learn anything from him. The company is solid and it’s navigating terrible macro setup. I am looking at a very long term investment plan here.
valueforme
Posted - 04/15/24
$MIRM December 31, 2022 - 196 employees, 26 PhD or MD. "Further, 157 of our employees are located in the United Sates, and 29 are located in Switzerland, two in the Netherlands, three in Italy, three in Germany and two in France" December 31, 2023 - 264 employees, 40 PhD or MD. "Further, 202 of our employees are located in the United States, and 56 in Europe and six in Canada."
valueforme
Posted - 04/15/24
$MIRM Has anyone read this part of 10-K? Especially the last paragraph. Usually people that are going to sell their company are not initiating new 5 year term leases for a way larger square footage.
LMXPERTEN
Posted - 04/15/24
$MIRM hahhahahaha!!!! Going down to the shiiiieeeeets. 200k for loading.
All ”Fantastic” investors in this forum GONE 😂
valueforme
Posted - 04/15/24
$MIRM Quiet here. Maybe because I blocked one bipolar character, lol.
Jokes aside,a year ago Mirum issued convertible senior notes that has been used to buy back royalty obligations. Conversion price on these notes is $31.74... A year ago the stock was very much where it is now
https://ir.mirumpharma.com/news-events/News/news-details/2023/Mirum-Pharmaceuticals-Prices-Upsized-275.0-Million-Convertible-Senior-Notes-Offering/default.aspx
LMXPERTEN
Posted - 04/12/24
$MIRM CEO missed up a lot! Should have sold the co before last readout. Way too greedy.
With neg IAs (likely) this one can be punished to the sub 20’s. Then CEO lost 50% of the co’s value with stupidity.
LMXPERTEN
Posted - 04/12/24
$MIRM krillionaire and geniousloci GONE. Real loosers and amat. 🤣
On way to 23s
